X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs4,560353-   
Low Rs4,400255-   
Sales per share (Unadj.) Rs1,028.5105.0-  
Earnings per share (Unadj.) Rs129.0-26.5-  
Cash flow per share (Unadj.) Rs186.0-21.9-  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.682.4-  
Shares outstanding (eoy) m23.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.42.9 150.5%   
Avg P/E ratio x34.7-11.5 -302.5%  
P/CF ratio (eoy) x24.1-13.9 -173.9%  
Price / Book Value ratio x5.93.7 161.3%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,17451,290 201.2%   
No. of employees `0003.64.3 84.4%   
Total wages/salary Rs m3,5923,219 111.6%   
Avg. sales/employee Rs Th6,537.74,129.2 158.3%   
Avg. wages/employee Rs Th991.4749.8 132.2%   
Avg. net profit/employee Rs Th819.8-1,040.5 -78.8%   
INCOME DATA
Net Sales Rs m23,68617,727 133.6%  
Other income Rs m708124 570.3%   
Total revenues Rs m24,39417,851 136.7%   
Gross profit Rs m5,281-3,072 -171.9%  
Depreciation Rs m1,313765 171.6%   
Interest Rs m15480 3.1%   
Profit before tax Rs m4,661-4,193 -111.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691262 645.4%   
Profit after tax Rs m2,970-4,467 -66.5%  
Gross profit margin %22.3-17.3 -128.7%  
Effective tax rate %36.3-6.2 -580.6%   
Net profit margin %12.5-25.2 -49.8%  
BALANCE SHEET DATA
Current assets Rs m15,67312,983 120.7%   
Current liabilities Rs m6,6787,305 91.4%   
Net working cap to sales %38.032.0 118.6%  
Current ratio x2.31.8 132.0%  
Inventory Days Days76111 68.5%  
Debtors Days Days22124 18.0%  
Net fixed assets Rs m8,0987,568 107.0%   
Share capital Rs m23082 279.8%   
"Free" reserves Rs m17,0880-   
Net worth Rs m17,35613,914 124.7%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m25,40026,284 96.6%  
Interest coverage x311.7-7.7 -4,031.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 138.3%   
Return on assets %11.8-15.2 -77.5%  
Return on equity %17.1-32.1 -53.3%  
Return on capital %26.9-19.8 -136.0%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Net fx Rs m2990-   
CASH FLOW
From Operations Rs m3,2261,513 213.2%  
From Investments Rs m-1,555-465 334.7%  
From Financial Activity Rs m-1,8184,438 -41.0%  
Net Cashflow Rs m-1475,486 -2.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare SANOFI INDIA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFE  ALKEM LABORATORIES  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 21, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS